Yetian Dong

机构：Zhejiang Lab, First Affiliated Hospital Zhejiang University, Zhejiang University

发表论文 14 篇 · 总被引 670 次 · h-index 5

代表论文

• A systematic review of SARS-CoV-2 vaccine candidates (2020 · Signal Transduction and Targeted Therapy · 被引 565)
• The way of SARS-CoV-2 vaccine development: success and challenges (2021 · Signal Transduction and Targeted Therapy · 被引 59)
• Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2 (2020 · Advanced Science · 被引 21)
• Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia (2025 · Experimental Hematology and Oncology · 被引 9)
• Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up result (2025 · Journal of Advanced Research · 被引 7)
• Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma (2025 · Bone Marrow Transplantation · 被引 4)